Carlo B Gambacorti-Passerini


Ontology type: schema:Person     


Person Info

NAME

Carlo B

SURNAME

Gambacorti-Passerini

Publications in SciGraph latest 50 shown

  • 2020-11-30 Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples in NATURE COMMUNICATIONS
  • 2020-11-27 STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma in LEUKEMIA
  • 2020-11-23 ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine in NATURE COMMUNICATIONS
  • 2020-08-28 Sex differences in oncogenic mutational processes in NATURE COMMUNICATIONS
  • 2020-06-22 Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study in LEUKEMIA
  • 2020-04-19 Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia in ANNALS OF HEMATOLOGY
  • 2020-02-05 Combined burden and functional impact tests for cancer driver discovery using DriverPower in NATURE COMMUNICATIONS
  • 2020-02-05 Analyses of non-coding somatic drivers in 2,658 cancer whole genomes in NATURE
  • 2020-02-05 Integrative pathway enrichment analysis of multivariate omics data in NATURE COMMUNICATIONS
  • 2020-02-05 Pan-cancer analysis of whole genomes in NATURE
  • 2020-02-05 Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis in COMMUNICATIONS BIOLOGY
  • 2020-02-05 Pathway and network analysis of more than 2500 whole cancer genomes in NATURE COMMUNICATIONS
  • 2020-01-17 Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients in SCIENTIFIC REPORTS
  • 2019-06-17 Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia in LEUKEMIA
  • 2019-04-15 Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2018-12-27 Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2018-12-03 Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma in NATURE MEDICINE
  • 2018-06-11 Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea in BLOOD CANCER JOURNAL
  • 2018-06-06 SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub in NATURE COMMUNICATIONS
  • 2017-05-22 Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes in SCIENTIFIC REPORTS
  • 2017-04-07 OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes in SCIENTIFIC REPORTS
  • 2016-06-03 Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis in SUPPORTIVE CARE IN CANCER
  • 2015-12-14 Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency in ONCOGENE
  • 2015-07-16 BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene in MOLECULAR CANCER
  • 2015-07-07 In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2014 Whole-Exome Sequencing Data – Identifying Somatic Mutations in SPRINGER HANDBOOK OF BIO-/NEUROINFORMATICS
  • 2013-04-30 SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations in LEUKEMIA
  • 2012-12-09 Recurrent SETBP1 mutations in atypical chronic myeloid leukemia in NATURE GENETICS
  • 2012 A Bioinformatics Procedure to Identify and Annotate Somatic Mutations in Whole-Exome Sequencing Data in COMPUTATIONAL INTELLIGENCE METHODS FOR BIOINFORMATICS AND BIOSTATISTICS
  • 2010-06-03 BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients in LEUKEMIA
  • 2010-05-06 Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib in LEUKEMIA
  • 2008-08-28 Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase in LEUKEMIA
  • 2007-02 Erratum: Corrigendum: In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' in NATURE MEDICINE
  • 2006-01-01 PNAs as Novel Cancer Therapeutics in PEPTIDE NUCLEIC ACIDS, MORPHOLINOS AND RELATED ANTISENSE BIOMOLECULES
  • 2005-10-25 Erratum: Abl inhibitor BMS354825 binding mode in Ableson kinase revealed by molecular docking studies in LEUKEMIA
  • 2005-10-20 Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by Leguay et al in LEUKEMIA
  • 2005-08-25 Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients in LEUKEMIA
  • 2005-04-28 Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies in LEUKEMIA
  • 2004-12 Oncogenic protein tyrosine kinases in CELLULAR AND MOLECULAR LIFE SCIENCES
  • 2004-10-28 Evidence for D276G and L364I Bcr-Abl mutations in Ph+ leukaemic cells obtained from patients resistant to Imatinib in LEUKEMIA
  • 2004-02-12 Response to Chand et al in LEUKEMIA
  • 2003-06 PNAs as novel cancer therapeutics in INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS
  • 2003-02-18 Effect of imatinib on haematopoietic recovery following idarubicin exposure in LEUKEMIA
  • 2001-12-20 BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2 in NATURE GENETICS
  • 2001 The immune response to oncogenic fusion proteins in CANCER IMMUNOLOGY
  • 1999-05 Too many agencies spoil Euro research in NATURE
  • 1995-10 The Role of the Immune System in Anti-Tumour Responses in DRUGS & AGING
  • 1994 Renal Cell Carcinoma in BIOLOGICAL MODULATION OF SOLID TUMOURS BY INTERFERONS
  • 1993-12 Immunogenicity of fusion proteins in INTERNATIONAL JOURNAL OF CLINICAL AND LABORATORY RESEARCH
  • 1993-09 Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2 in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.7563.7", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412301.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413648.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8158.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6292.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5608.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476471.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.13648.38", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415025.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6738.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14709.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7841.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.428736.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9027.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411347.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8591.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414818.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10306.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4708.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.28803.31", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411947.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14003.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414966.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414980.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.428999.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4527.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4280.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412639.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.21729.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476071.3", 
            "type": "Organization"
          }
        ], 
        "familyName": "Gambacorti-Passerini", 
        "givenName": "Carlo B", 
        "id": "sg:person.01142072234.65", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0001-6058-515X"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142072234.65", 
          "https://orcid.org/0000-0001-6058-515X"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-01-01T19:56", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/person/person_714.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01142072234.65'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01142072234.65'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01142072234.65'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01142072234.65'


     

    This table displays all metadata directly associated to this object as RDF triples.

    81 TRIPLES      11 PREDICATES      43 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01142072234.65 schema:affiliation Nb8474d01a86d4d9c83257a3cdf8df9b2
    2 grid-institutes:grid.10306.34
    3 grid-institutes:grid.13648.38
    4 grid-institutes:grid.14003.36
    5 grid-institutes:grid.14709.3b
    6 grid-institutes:grid.21729.3f
    7 grid-institutes:grid.28803.31
    8 grid-institutes:grid.411347.4
    9 grid-institutes:grid.411947.e
    10 grid-institutes:grid.412301.5
    11 grid-institutes:grid.412639.b
    12 grid-institutes:grid.413648.c
    13 grid-institutes:grid.414818.0
    14 grid-institutes:grid.414966.8
    15 grid-institutes:grid.414980.0
    16 grid-institutes:grid.415025.7
    17 grid-institutes:grid.417893.0
    18 grid-institutes:grid.4280.e
    19 grid-institutes:grid.428736.c
    20 grid-institutes:grid.428999.7
    21 grid-institutes:grid.4527.4
    22 grid-institutes:grid.4708.b
    23 grid-institutes:grid.476071.3
    24 grid-institutes:grid.476471.7
    25 grid-institutes:grid.5608.b
    26 grid-institutes:grid.6292.f
    27 grid-institutes:grid.6738.a
    28 grid-institutes:grid.7841.a
    29 grid-institutes:grid.8158.4
    30 grid-institutes:grid.8591.5
    31 grid-institutes:grid.9027.c
    32 schema:familyName Gambacorti-Passerini
    33 schema:givenName Carlo B
    34 schema:identifier N903b5fb7bc0d47478c31f66de694c67f
    35 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142072234.65
    36 https://orcid.org/0000-0001-6058-515X
    37 schema:sdDatePublished 2022-01-01T19:56
    38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    39 schema:sdPublisher N5bb9c4eaa8d640cca098f97a03482511
    40 sgo:license sg:explorer/license/
    41 sgo:sdDataset persons
    42 rdf:type schema:Person
    43 N5bb9c4eaa8d640cca098f97a03482511 schema:name Springer Nature - SN SciGraph project
    44 rdf:type schema:Organization
    45 N903b5fb7bc0d47478c31f66de694c67f schema:name orcid_id
    46 schema:value 0000-0001-6058-515X
    47 rdf:type schema:PropertyValue
    48 Nb8474d01a86d4d9c83257a3cdf8df9b2 schema:affiliation grid-institutes:grid.7563.7
    49 sgo:isCurrent true
    50 rdf:type schema:OrganizationRole
    51 grid-institutes:grid.10306.34 schema:Organization
    52 grid-institutes:grid.13648.38 schema:Organization
    53 grid-institutes:grid.14003.36 schema:Organization
    54 grid-institutes:grid.14709.3b schema:Organization
    55 grid-institutes:grid.21729.3f schema:Organization
    56 grid-institutes:grid.28803.31 schema:Organization
    57 grid-institutes:grid.411347.4 schema:Organization
    58 grid-institutes:grid.411947.e schema:Organization
    59 grid-institutes:grid.412301.5 schema:Organization
    60 grid-institutes:grid.412639.b schema:Organization
    61 grid-institutes:grid.413648.c schema:Organization
    62 grid-institutes:grid.414818.0 schema:Organization
    63 grid-institutes:grid.414966.8 schema:Organization
    64 grid-institutes:grid.414980.0 schema:Organization
    65 grid-institutes:grid.415025.7 schema:Organization
    66 grid-institutes:grid.417893.0 schema:Organization
    67 grid-institutes:grid.4280.e schema:Organization
    68 grid-institutes:grid.428736.c schema:Organization
    69 grid-institutes:grid.428999.7 schema:Organization
    70 grid-institutes:grid.4527.4 schema:Organization
    71 grid-institutes:grid.4708.b schema:Organization
    72 grid-institutes:grid.476071.3 schema:Organization
    73 grid-institutes:grid.476471.7 schema:Organization
    74 grid-institutes:grid.5608.b schema:Organization
    75 grid-institutes:grid.6292.f schema:Organization
    76 grid-institutes:grid.6738.a schema:Organization
    77 grid-institutes:grid.7563.7 schema:Organization
    78 grid-institutes:grid.7841.a schema:Organization
    79 grid-institutes:grid.8158.4 schema:Organization
    80 grid-institutes:grid.8591.5 schema:Organization
    81 grid-institutes:grid.9027.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...